Global Age-Related Macular Degeneration (AMD) Therapeutics Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2017-2028

2.1.2 Age-Related Macular Degeneration (AMD) Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Age-Related Macular Degeneration (AMD) Therapeutics Segment by Type

2.2.1 Wet AMD

2.2.2 Dry AMD

2.3 Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type

2.3.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Type (2017-2022)

2.4 Age-Related Macular Degeneration (AMD) Therapeutics Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Research Institute

2.4.4 Other

2.5 Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application

2.5.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Application (2017-2022)

3 Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Player

3.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Players

3.1.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Players (2020-2022)

3.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Players (2020-2022)

3.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Age-Related Macular Degeneration (AMD) Therapeutics by Regions

4.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions (2017-2022)

4.2 Americas Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth (2017-2022)

4.3 APAC Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth (2017-2022)

4.4 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth (2017-2022)

4.5 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2017-2022)

5.2 Americas Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2017-2022)

5.3 Americas Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2017-2022)

6.2 APAC Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2017-2022)

6.3 APAC Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics by Country (2017-2022)

7.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2017-2022)

7.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics by Region (2017-2022)

8.2 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2017-2022)

8.3 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecast by Regions (2023-2028)

10.1.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecast by Regions (2023-2028)

10.1.2 Americas Age-Related Macular Degeneration (AMD) Therapeutics Forecast

10.1.3 APAC Age-Related Macular Degeneration (AMD) Therapeutics Forecast

10.1.4 Europe Age-Related Macular Degeneration (AMD) Therapeutics Forecast

10.1.5 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Forecast

10.2 Americas Age-Related Macular Degeneration (AMD) Therapeutics Forecast by Country (2023-2028)

10.2.1 United States Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.2.2 Canada Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.2.3 Mexico Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.2.4 Brazil Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.3 APAC Age-Related Macular Degeneration (AMD) Therapeutics Forecast by Region (2023-2028)

10.3.1 China Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.3.2 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.3.3 Korea Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.3.4 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.3.5 India Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.3.6 Australia Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.4 Europe Age-Related Macular Degeneration (AMD) Therapeutics Forecast by Country (2023-2028)

10.4.1 Germany Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.4.2 France Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.4.3 UK Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.4.4 Italy Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.4.5 Russia Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.5 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Forecast by Region (2023-2028)

10.5.1 Egypt Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.5.2 South Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.5.3 Israel Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.5.4 Turkey Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.5.5 GCC Countries Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast

10.6 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecast by Type (2023-2028)

10.7 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Amgen Inc.

11.1.1 Amgen Inc. Company Information

11.1.2 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Offered

11.1.3 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Amgen Inc. Main Business Overview

11.1.5 Amgen Inc. Latest Developments

11.2 Bausch Health Companies, Inc.

11.2.1 Bausch Health Companies, Inc. Company Information

11.2.2 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Offered

11.2.3 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Bausch Health Companies, Inc. Main Business Overview

11.2.5 Bausch Health Companies, Inc. Latest Developments

11.3 F. Hoffmann-La Roche Ltd.

11.3.1 F. Hoffmann-La Roche Ltd. Company Information

11.3.2 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product Offered

11.3.3 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 F. Hoffmann-La Roche Ltd. Main Business Overview

11.3.5 F. Hoffmann-La Roche Ltd. Latest Developments

11.4 Novartis AG

11.4.1 Novartis AG Company Information

11.4.2 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product Offered

11.4.3 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Novartis AG Main Business Overview

11.4.5 Novartis AG Latest Developments

11.5 Regeneron Pharmaceuticals Inc.

11.5.1 Regeneron Pharmaceuticals Inc. Company Information

11.5.2 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Offered

11.5.3 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Regeneron Pharmaceuticals Inc. Main Business Overview

11.5.5 Regeneron Pharmaceuticals Inc. Latest Developments

12 Research Findings and Conclusion

Table 1. Age-Related Macular Degeneration (AMD) Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Wet AMD

Table 3. Major Players of Dry AMD

Table 4. Age-Related Macular Degeneration (AMD) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Type (2017-2022)

Table 7. Age-Related Macular Degeneration (AMD) Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Application (2017-2022)

Table 10. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Player (2020-2022)

Table 12. Age-Related Macular Degeneration (AMD) Therapeutics Key Players Head office and Products Offered

Table 13. Age-Related Macular Degeneration (AMD) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Regions (2017-2022)

Table 18. Americas Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Country (2017-2022)

Table 20. Americas Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Type (2017-2022)

Table 22. Americas Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Application (2017-2022)

Table 24. APAC Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Region (2017-2022)

Table 26. APAC Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Type (2017-2022)

Table 28. APAC Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Application (2017-2022)

Table 30. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Country (2017-2022)

Table 32. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Type (2017-2022)

Table 34. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Age-Related Macular Degeneration (AMD) Therapeutics

Table 43. Key Market Challenges & Risks of Age-Related Macular Degeneration (AMD) Therapeutics

Table 44. Key Industry Trends of Age-Related Macular Degeneration (AMD) Therapeutics

Table 45. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share Forecast by Application (2023-2028)

Table 51. Amgen Inc. Details, Company Type, Age-Related Macular Degeneration (AMD) Therapeutics Area Served and Its Competitors

Table 52. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Offered

Table 53. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Amgen Inc. Main Business

Table 55. Amgen Inc. Latest Developments

Table 56. Bausch Health Companies, Inc. Details, Company Type, Age-Related Macular Degeneration (AMD) Therapeutics Area Served and Its Competitors

Table 57. Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Offered

Table 58. Bausch Health Companies, Inc. Main Business

Table 59. Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Bausch Health Companies, Inc. Latest Developments

Table 61. F. Hoffmann-La Roche Ltd. Details, Company Type, Age-Related Macular Degeneration (AMD) Therapeutics Area Served and Its Competitors

Table 62. F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product Offered

Table 63. F. Hoffmann-La Roche Ltd. Main Business

Table 64. F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. F. Hoffmann-La Roche Ltd. Latest Developments

Table 66. Novartis AG Details, Company Type, Age-Related Macular Degeneration (AMD) Therapeutics Area Served and Its Competitors

Table 67. Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product Offered

Table 68. Novartis AG Main Business

Table 69. Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Novartis AG Latest Developments

Table 71. Regeneron Pharmaceuticals Inc. Details, Company Type, Age-Related Macular Degeneration (AMD) Therapeutics Area Served and Its Competitors

Table 72. Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Offered

Table 73. Regeneron Pharmaceuticals Inc. Main Business

Table 74. Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Regeneron Pharmaceuticals Inc. Latest Developments

List of Figures

Figure 1. Age-Related Macular Degeneration (AMD) Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Type in 2021

Figure 7. Age-Related Macular Degeneration (AMD) Therapeutics in Hospital

Figure 8. Global Age-Related Macular Degeneration (AMD) Therapeutics Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Age-Related Macular Degeneration (AMD) Therapeutics in Clinic

Figure 10. Global Age-Related Macular Degeneration (AMD) Therapeutics Market: Clinic (2017-2022) & ($ Millions)

Figure 11. Age-Related Macular Degeneration (AMD) Therapeutics in Research Institute

Figure 12. Global Age-Related Macular Degeneration (AMD) Therapeutics Market: Research Institute (2017-2022) & ($ Millions)

Figure 13. Age-Related Macular Degeneration (AMD) Therapeutics in Other

Figure 14. Global Age-Related Macular Degeneration (AMD) Therapeutics Market: Other (2017-2022) & ($ Millions)

Figure 15. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Application in 2021

Figure 16. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Player in 2021

Figure 17. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2017-2022 ($ Millions)

Figure 19. APAC Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2017-2022 ($ Millions)

Figure 20. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2017-2022 ($ Millions)

Figure 22. Americas Age-Related Macular Degeneration (AMD) Therapeutics Value Market Share by Country in 2021

Figure 23. Americas Age-Related Macular Degeneration (AMD) Therapeutics Consumption Market Share by Type in 2021

Figure 24. Americas Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Application in 2021

Figure 25. United States Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Region in 2021

Figure 30. APAC Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Application in 2021

Figure 31. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Country in 2021

Figure 38. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Type in 2021

Figure 39. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Application in 2021

Figure 40. Germany Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Application in 2021

Figure 48. Egypt Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 54. APAC Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 55. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 57. United States Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 58. Canada Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 61. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 62. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 63. Korea Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 65. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 66. Australia Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 67. Germany Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 68. France Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 69. UK Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 70. Italy Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 71. Russia Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 72. Spain Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 75. Israel Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2023-2028 ($ Millions)